Logo image of UXIN

UXIN LTD - ADR (UXIN) Stock Fundamental Analysis

NASDAQ:UXIN - Nasdaq - US91818X3061 - ADR - Currency: USD

4.27  -0.09 (-2.06%)

Fundamental Rating

1

Taking everything into account, UXIN scores 1 out of 10 in our fundamental rating. UXIN was compared to 120 industry peers in the Specialty Retail industry. UXIN has a bad profitability rating. Also its financial health evaluation is rather negative. UXIN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year UXIN has reported negative net income.
In the past 5 years UXIN always reported negative net income.
In the past 5 years UXIN always reported negative operating cash flow.
UXIN Yearly Net Income VS EBIT VS OCF VS FCFUXIN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 -1B -2B -3B

1.2 Ratios

UXIN has a worse Return On Assets (-111.19%) than 99.17% of its industry peers.
Industry RankSector Rank
ROA -111.19%
ROE N/A
ROIC N/A
ROA(3y)-84.07%
ROA(5y)-64.66%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
UXIN Yearly ROA, ROE, ROICUXIN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K -1.5K

1.3 Margins

UXIN's Gross Margin of 6.15% is on the low side compared to the rest of the industry. UXIN is outperformed by 95.83% of its industry peers.
UXIN's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for UXIN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 6.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-30.55%
UXIN Yearly Profit, Operating, Gross MarginsUXIN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

More info and screens

0

2. Health

2.1 Basic Checks

UXIN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for UXIN has been increased compared to 1 year ago.
The number of shares outstanding for UXIN has been increased compared to 5 years ago.
The debt/assets ratio for UXIN has been reduced compared to a year ago.
UXIN Yearly Shares OutstandingUXIN Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
UXIN Yearly Total Debt VS Total AssetsUXIN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

UXIN has an Altman-Z score of -12.64. This is a bad value and indicates that UXIN is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -12.64, UXIN is not doing good in the industry: 96.67% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -12.64
ROIC/WACCN/A
WACC7.55%
UXIN Yearly LT Debt VS Equity VS FCFUXIN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B -2B

2.3 Liquidity

A Current Ratio of 0.44 indicates that UXIN may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.44, UXIN is doing worse than 95.00% of the companies in the same industry.
A Quick Ratio of 0.19 indicates that UXIN may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.19, UXIN is doing worse than 90.83% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.44
Quick Ratio 0.19
UXIN Yearly Current Assets VS Current LiabilitesUXIN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 96.80% over the past year.
UXIN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.49%.
The Revenue has been growing by 15.84% on average over the past years. This is quite good.
EPS 1Y (TTM)96.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.93%
Revenue 1Y (TTM)11.49%
Revenue growth 3Y27.89%
Revenue growth 5Y15.84%
Sales Q2Q%44.16%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y33.33%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year17.05%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
UXIN Yearly Revenue VS EstimatesUXIN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B
UXIN Yearly EPS VS EstimatesUXIN Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 -20 -40 -60 -80 -100

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for UXIN. In the last year negative earnings were reported.
Also next year UXIN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
UXIN Price Earnings VS Forward Price EarningsUXIN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
UXIN Per share dataUXIN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6 -8 -10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

UXIN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

UXIN LTD - ADR

NASDAQ:UXIN (5/29/2025, 10:00:08 AM)

4.27

-0.09 (-2.06%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)04-23 2025-04-23
Earnings (Next)07-29 2025-07-29/amc
Inst Owners0.03%
Inst Owner Change498.3%
Ins Owners0.13%
Ins Owner ChangeN/A
Market Cap802.53M
Analysts43.33
Price TargetN/A
Short Float %3.81%
Short Ratio8.26
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.55
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-12.1
EYN/A
EPS(NY)-0.17
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.2
BVpS-0.25
TBVpS-0.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -111.19%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 6.15%
FCFM N/A
ROA(3y)-84.07%
ROA(5y)-64.66%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-30.55%
F-ScoreN/A
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.44
Quick Ratio 0.19
Altman-Z -12.64
F-ScoreN/A
WACC7.55%
ROIC/WACCN/A
Cap/Depr(3y)92.95%
Cap/Depr(5y)65.68%
Cap/Sales(3y)1.23%
Cap/Sales(5y)1.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)96.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.93%
EPS Next Y33.33%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)11.49%
Revenue growth 3Y27.89%
Revenue growth 5Y15.84%
Sales Q2Q%44.16%
Revenue Next Year17.05%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-0.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year43.39%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y3.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-4.32%
OCF growth 3YN/A
OCF growth 5YN/A